Nucleic acid aptamers are innovative and promising candidates to block the hallmark event in the prion diseases, that is the conversion of prion protein (PrP) into an abnormal form; however, they need chemical modifications for effective therapeutic activity. This communication reports on the development and biophysical characterization of a small library of chemically modified G-quadruplex-forming aptamers targeting the cellular PrP and the evaluation of their anti-prion activity. The results show the possibility of enhancing anti-prion aptamer properties through straightforward modifications.
Get full access to this article
View all access options for this article.
References
1.
Prusiner SB. (1998). Prions. Proc Natl Acad Sci U S A, 95:13363–13383.
2.
PrusinerSB, ScottMR, DeArmondSJ and CohenFE. (1998). Prion protein biology. Cell, 93:337–348.
3.
PanKM, BaldwinM, NguyenJ, GassetM, SerbanA, GrothD, MehlhornI, HuangZ, FletterickRJ and CohenFE. (1993). Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci U S A, 90:10962–10966.
4.
CashmanNR and CaugheyB. (2004). Prion diseases—close to effective therapy? Nat Rev Drug Discov, 3:874–884.
5.
AguzziA, LakkarajuAKK and FrontzekK. (2018). Toward therapy of human prion diseases. Annu Rev Pharmacol Toxicol, 58:331–351.
MashimaT, NishikawaF, KamatariYO, FujiwaraH, SaimuraM, NagataT, KodakiT, NishikawaS, KuwataK and KatahiraM. (2013). Anti-prion activity of an RNA aptamer and its structural basis. Nucleic Acids Res, 41:1355–1362.
8.
KeefeAD, PaiS and EllingtonA. (2010). Aptamers as therapeutics. Nat Rev Drug Discov, 9:537–550.
9.
TolleF and MayerG. (2013). Dressed for success—applying chemistry to modulate aptamer functionality. Chem Sci, 4:60–67.
10.
WeissS, ProskeD, NeumannM, GroschupMH, KretzschmarHA, FamulokM and WinnackerEL. (1997). RNA aptamers specifically interact with the prion protein PrP. J Virol, 71:8790–8797.
11.
MurakamiK, NishikawaF, NodaK, YokoyamaT and NishikawaS. (2008). Anti-bovine Prion protein RNA aptamer containing tandem GGA repeat interacts both with recombinant bovine prion protein and its β isoform with high affinity. Prion, 2:73–80.
12.
CollieGW and ParkinsonGN. (2011). The application of DNA and RNA G-quadruplexes to therapeutic medicines. Chem Soc Rev, 40:5867–5892.
13.
BhattacharyyaD, Mirihana ArachchilageG and Basu.S (2016). Metal cations in G-quadruplex folding and stability. Front Chem, 4:38.
14.
PaganoB, MattiaCA, CavalloL, UesugiS, GiancolaC and FraternaliF. (2008). Stability and cations coordination of DNA and RNA 14-Mer G-quadruplexes: a multiscale computational approach. J Phys Chem B, 112:12115–12123.
15.
MashimaT, MatsugamiA, NishikawaF, NishikawaS and KatahiraM. (2009). Unique quadruplex structure and interaction of an RNA aptamer against bovine prion protein. Nucleic Acids Res, 37:6249–6258.
16.
MashimaT, LeeJ-H, KamatariYO, HayashiT, NagataT, NishikawaF, NishikawaS, KinoshitaM, KuwataK and Katahira.M (2020). Development and structural determination of an anti-PrPC aptamer that blocks pathological conformational conversion of prion protein. Sci Rep, 10:4934.
17.
MatsugamiA, OuhashiK, KanagawaM, LiuH, KanagawaS, UesugiS and KatahiraM. (2001). An intramolecular quadruplex of (GGA)4 triplet repeat DNA with a G:G:G:G tetrad and a G(:A):G(:A):G(:A):G heptad, and its dimeric interaction. J Mol Biol, 313:255–269.
18.
MatsugamiA, OkuizumiT, UesugiS and KatahiraM. (2003). Intramolecular higher order packing of parallel quadruplexes comprising a G:G:G:G tetrad and a G(:A):G(:A):G(:A):G heptad of GGA triplet repeat DNA. J Biol Chem, 278:28147–28153.
19.
CavaliereP, PaganoB, GranataV, PrigentS, RezaeiH, GiancolaC and ZagariA. (2013). Cross-talk between prion protein and quadruplex-forming nucleic acids: a dynamic complex formation. Nucleic Acids Res, 41:327–339.
20.
PaganoB, MartinoL, RandazzoA and GiancolaC. (2008). Stability and binding properties of a modified thrombin binding aptamer. Biophys J, 94:562–569.
21.
KratschmerC and LevyM. (2017). Effect of chemical modifications on aptamer stability in serum. Nucleic Acid Ther, 27:335–344.
22.
RezaeiH, MarcD, ChoisetY, TakahashiM, Hui Bon HoaG, HaertléT, GrosclaudeJ and DebeyP. (2000). High yield purification and physico-chemical properties of full-length recombinant allelic variants of sheep prion protein linked to scrapie susceptibility. Eur J Biochem, 267:2833–2839.
23.
CantorCR, WarshawMM and ShapiroH. (1970). Oligonucleotide interactions. III. Circular dichroism studies of the conformation of deoxyoligonucleolides. Biopolymers, 9:1059–1077.
24.
HwangTL and ShakaAJ. (1995). Water suppression that works. excitation sculpting using arbitrary wave-forms and pulsed-field gradients. J Magn Reson Ser A, 112:275–279.
25.
MarkyLA and BreslauerKJ. (1987). Calculating thermodynamic data for transitions of any molecularity from equilibrium melting curves. Biopolymers, 26:1601–1620.
26.
KarlssonR, KatsambaPS, NordinH, PolE and MyszkaDG. (2006). Analyzing a kinetic titration series using affinity biosensors. Anal Biochem, 349:136–147.
27.
KuwataK, NishidaN, MatsumotoT, KamatariYO, Hosokawa-MutoJ, KodamaK, NakamuraHK, KimuraK, KawasakiM, et al. (2007). Hot spots in prion protein for pathogenic conversion. Proc Natl Acad Sci U S A, 104:11921–11926.
28.
KimuraT, Hosokawa-MutoJ, KamatariYO and KuwataK. (2011). Synthesis of GN8 derivatives and evaluation of their antiprion activity in TSE-infected cells. Bioorg Med Chem Lett, 21:1502–1507.
29.
NishidaN, HarrisDA, ViletteD, LaudeH, FrobertY, GrassiJ, CasanovaD, MilhavetO and LehmannS. (2000). Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein. J Virol, 74:320–325.
30.
LiZ, LechCJ and PhanAT. (2014). Sugar-modified G-quadruplexes: effects of LNA-, 2′F-RNA- and 2′F-ANA-guanosine chemistries on G-quadruplex structure and stability. Nucleic Acids Res, 42:4068–4079.
31.
Martín-PintadoN, Yahyaee-AnzahaeeM, DeleaveyGF, PortellaG, OrozcoM, DamhaMJ and GonzálezC. (2013). Dramatic effect of furanose C2′ substitution on structure and stability: directing the folding of the human telomeric quadruplex with a single fluorine atom. J Am Chem Soc, 135:5344–5347.
32.
RandazzoA, SpadaGP and Webba da SilvaM. (2013). Circular dichroism of quadruplex structures. Top Curr Chem, 330:67–86.
33.
GiancolaC and PaganoB. (2013). Energetics of ligand binding to G-quadruplexes. Top Curr Chem, 330:211–242.
34.
PaganoB, RandazzoA, FotticchiaI, NovellinoE, PetracconeL and GiancolaC. (2013). Differential scanning calorimetry to investigate G-quadruplexes structural stability. Methods, 64:43–51.
35.
FotticchiaI, AmatoJ, PaganoB, NovellinoE, PetracconeL and GiancolaC. (2015). How are thermodynamically stable G-quadruplex–duplex hybrids? J Therm Anal Calorim, 121:1121–1127.
36.
LiuH, MatsugamiA, KatahiraM and UesugiS. (2002). A dimeric RNA quadruplex architecture comprised of two G:G(:A):G:G(:A) hexads, G:G:G:G tetrads and UUUU loops. J Mol Biol, 322:955–970.
37.
Medic ŠP Podbevšek and PlavecJ. (2014). Solution structure of a prion protein aptamer analogue. Croat Chem Acta, 87:321–325.
38.
KotkowiakW, WengelJ, ScottonCJ and PasternakA. (2019). Improved RE31 analogues containing modified nucleic acid monomers: thermodynamic, structural, and biological effects. J Med Chem, 62:2499–2507.
39.
PasternakA, HernandezFJ, RasmussenLM, VesterB and WengelJ. (2011). Improved thrombin binding aptamer by incorporation of a single unlocked nucleic acid monomer. Nucleic Acids Res, 39:1155–1164.
40.
PradhanP, SrivastavaA, SinghJ, BiswasB, SainiA, SiddiqueI, KumariP, KhanMA, MishraA, et al. (2020). Prion protein transcription is auto-regulated through dynamic interactions with G-quadruplex motifs in its own promoter. Biochim Biophys Acta Gene Regul Mech, 1863:194479.
41.
AmatoJ, CerofoliniL, BrancaccioD, GiuntiniS, IaccarinoN, ZizzaP, IachettiniS, BiroccioA, NovellinoE, et al. (2019). Insights into telomeric G-quadruplex DNA recognition by HMGB1 protein. Nucleic Acids Res, 47:9950–9966.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
